Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

Clinical trial NCT05660538 · COMPLETED

Trial details

NCT number: NCT05660538
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathy

Start date: 2022-12-20
Primary completion: 2023-10-12
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.